Data mining analysis of the prognostic impact of N6-methyladenosine regulators in patients with endometrial adenocarcinoma
© The author(s)..
We reanalyzed the expression of 16 acknowledged N6-methyladenosine (m6A) RNA regulators in 406 endometrial adenocarcinoma patients and 19 controls using The Cancer Genome Atlas (TCGA) dataset, and further verified our results using Gene Expression Omnibus (GEO) dataset and real-time quantitative polymerase chain reaction. Thirteen m6A RNA methylation regulators were differentially expressed between patients with endometrial adenocarcinoma and controls. FTO, RBM15, and YTHDF1, were identified as independent prognostic markers and closely associated with International Federation of Gynecology and Obstetrics grade in endometrial cancer patients. GEO dataset also verified the differential expression of FTO and RBM15 between patients with endometrial adenocarcinoma and hyperplasia. Functional enrichment and ingenuity pathway analysis network suggested that FTO and RBM15 contributed to the survival of patients with endometrial adenocarcinoma via the regulation of connective tissue development, catabolic process, RNA stability, oxidative demethylation, temperature homeostasis, and energy metabolism through IGF1, IRS1, RBM24, LARP1, and CBFA2T3. The decreased FTO expression and increased RBM15 expression in endometrial adenocarcinoma from our validation cohort was consistent with in silico analysis using TCGA and GEO datasets. In conclusion, m6A methylation regulators, especially FTO, RBM15, and YTHDF1, are critical in the progression and prognosis of endometrial adenocarcinoma.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
Journal of Cancer - 12(2021), 15 vom: 02., Seite 4729-4738 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhai, Junyu [VerfasserIn] |
---|
Links: |
---|
Themen: |
Endometrial Adenocarcinoma |
---|
Anmerkungen: |
Date Revised 22.06.2021 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.7150/jca.50868 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM326973907 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM326973907 | ||
003 | DE-627 | ||
005 | 20231225195741.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.7150/jca.50868 |2 doi | |
028 | 5 | 2 | |a pubmed24n1089.xml |
035 | |a (DE-627)NLM326973907 | ||
035 | |a (NLM)34149936 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhai, Junyu |e verfasserin |4 aut | |
245 | 1 | 0 | |a Data mining analysis of the prognostic impact of N6-methyladenosine regulators in patients with endometrial adenocarcinoma |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 22.06.2021 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © The author(s). | ||
520 | |a We reanalyzed the expression of 16 acknowledged N6-methyladenosine (m6A) RNA regulators in 406 endometrial adenocarcinoma patients and 19 controls using The Cancer Genome Atlas (TCGA) dataset, and further verified our results using Gene Expression Omnibus (GEO) dataset and real-time quantitative polymerase chain reaction. Thirteen m6A RNA methylation regulators were differentially expressed between patients with endometrial adenocarcinoma and controls. FTO, RBM15, and YTHDF1, were identified as independent prognostic markers and closely associated with International Federation of Gynecology and Obstetrics grade in endometrial cancer patients. GEO dataset also verified the differential expression of FTO and RBM15 between patients with endometrial adenocarcinoma and hyperplasia. Functional enrichment and ingenuity pathway analysis network suggested that FTO and RBM15 contributed to the survival of patients with endometrial adenocarcinoma via the regulation of connective tissue development, catabolic process, RNA stability, oxidative demethylation, temperature homeostasis, and energy metabolism through IGF1, IRS1, RBM24, LARP1, and CBFA2T3. The decreased FTO expression and increased RBM15 expression in endometrial adenocarcinoma from our validation cohort was consistent with in silico analysis using TCGA and GEO datasets. In conclusion, m6A methylation regulators, especially FTO, RBM15, and YTHDF1, are critical in the progression and prognosis of endometrial adenocarcinoma | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Endometrial Adenocarcinoma | |
650 | 4 | |a Energy Metabolism | |
650 | 4 | |a N6-methyladenosine | |
650 | 4 | |a RNA-Binding Protein | |
700 | 1 | |a Li, Shang |e verfasserin |4 aut | |
700 | 1 | |a Li, Yu |e verfasserin |4 aut | |
700 | 1 | |a Du, Yanzhi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of Cancer |d 2010 |g 12(2021), 15 vom: 02., Seite 4729-4738 |w (DE-627)NLM201575388 |x 1837-9664 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2021 |g number:15 |g day:02 |g pages:4729-4738 |
856 | 4 | 0 | |u http://dx.doi.org/10.7150/jca.50868 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 12 |j 2021 |e 15 |b 02 |h 4729-4738 |